Posted on 10/26/2021 9:15:16 PM PDT by SeekAndFind
U.S. vaccine maker Novavax announced that it has applied to the World Health Organization (WHO) for emergency use approval of its COVID-19 vaccine. If approved, Novavax’s vaccine has the potential to help equalize global access to COVID-19 vaccines, but the firm still faces steep regulatory and manufacturing issues before it can contribute to the worldwide rollout.
"Today's submission of our protein-based COVID-19 vaccine to WHO for emergency use listing is a significant step on the path to accelerating access and more equitable distribution to countries in great need around the world," Stanley Erck, president and CEO of Novavax, said in a press release on Thursday.
Novavax’s jab would be the first protein subunit COVID-19 vaccine to win WHO approval, and the technology, which trains the immune system to fight COVID-19 through a protein that contains part of the disease pathogen, offers several distinct advantages over other vaccines.
Unlike mRNA shots from Pfizer and Moderna that require sub-zero temperatures for transport and storage, Novavax’s shots can be kept at normal refrigerated temperatures (2 to 8 degrees Celsius).
In trials, Novavax’s vaccine produced less severe side effects than the mRNA jabs even as it demonstrated similar efficacy against the virus. Phase III trials showed that the vaccine was 90.4% effective in preventing symptomatic cases of COVID-19. Novavax also said in early August that a booster dose of its vaccine created six times more antibodies associated with fighting off the Delta variant of COVID-19 than its initial two-dose regimen.
But the challenges facing Novavax do not stem from how well the vaccine appears to work. Rather, Novavax has struggled to find a way to produce its shots.
(Excerpt) Read more at fortune.com ...
SO, WHAT’s HOLDING UP THE NOVAVAX COVID VACCINE?
Novavax says it is currently producing COVID-19 vaccines at 20 plants globally and will have the capacity to make 2 billion vaccines in 2022, but none of the firm’s vaccines are currently being used beyond clinical trials.
In the U.S., Novavax has yet to apply to the Food and Drug Administration (FDA) for emergency use authorization and says it may not apply for approval until the fourth quarter of this year after months of delays.
U.S. regulators told the New York Times in August that the hold-up stemmed from poor quality control at Novavax’s manufacturing facilities. Novavax later said a contract it signed with the U.S. government has constrained its ability to produce doses. Since July 2020, Novavax has received $1.75 billion from former President Donald Trump’s Operation Warp Speed to develop and manufacture its vaccines.
As part of the deal, Novavax says that it was directed to work with manufacturers including the Japanese-owned and U.S.-headquartered pharmaceutical manufacturer Fujifilm Diosynth Biotechnologies, which has slowed production.
The article is more than a month old and I’m not sure what real progress Novavax has made.
RE: The article is more than a month old and I’m not sure what real progress Novavax has made.
Things are Exactly the same as a month ago. In fact, investors are so pissed at no apparent progress that they’re dumping the company’s stocks even as I write this.
I thought Novavax was promising and why i invested in it back in 2020. I sold it before it ran up to over $300, but now it’s back to where it was when i sold over a year ago. Sounds like their false promises haven’t changed.
Just amazing how all these companies are working so diligently to develop vaccines for a virus which has always had about a 99.7 percent survival rate.
You might think they were busy trying to recoup the bucks they lost back when President Trump succeeded in getting prescription drug prices lowered.
We don’t need anymore damn Covid vaccines. They’re doing enough damage with what they’ve got. I’m so tired of this crap.
The globalists are not going to give us a choice between having damaing mRNA or DNA/Adenoviral vectors, or some other vaccine that's actually harmless. All are bioweapons pushed by the weaponized wing of the Biden Regime.
My notes on Dr. John Campbell's video "TUESDAY UPDATE" in which he reviews Novavax and a small Ivermectin study in Israel.
youtube.com ^ | Jun 15, 2021 | Dr. John Campbell and vanity
The long shot [Novavax Covid Vaccine]
sciencemag.org ^ | 06 Nov 2020: | Meredith Wadman
I’m at the point now, I trust nothing. 98% survivable. I use what God gave me.
We gave Novavax all that money... and we're still waiting?
Novavax doesn’t sponsor tv programs or pay off politicians.
What is holding it up, you ask?
$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
Existing Pharm companies with their fake mRNA vaxxes has established pay-back schemes for politicos and MSM creeps who push the narrative. Anyone wanting to enter the cash fest needs to step up and make an offer.
If it actually contains a bit of the actual Covid bug that will be a first, except for the CCP vaccine that is failing so terribly in SAmerica.
And what major powers in this realm could possibly be fighting it tooth and nail, as they did with Ivermectin? Hmm?
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.